Responses
Clinical and epidemiological research
Extended report
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
Compose a Response to This Article
Other responses
No responses have been published for this article.